The "Night Vision Disturbances Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report delivers an in depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of NVDs in the United States. The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Night Vision Disturbances (NVD) from 2017 to 2028 in the United States. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
The report provides disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. It also provides treatment algorithms and treatment guidelines for Night Vision Disturbances in the US, Europe and Japan.
The Night Vision Disturbances (NVD) epidemiology division provide the insights about historical and current patient pool and forecasted trend for 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Incident Cases of NVD in the United States, Incident cases of NVD by Type of Surgeries, Incidence of NVD Manifestations) scenario of Night Vision Disturbances (NVD)in the United States from 2017 - 2028.
Night Vision Disturbances Drug Chapters
This segment of the Night Vision Disturbances report encloses the detailed analysis of late stage (Phase - II) drug, Nyxol. Nyxol (Lynx - 1) is a novel eye drop treatment for multiple front - of - the - eye disorders, including night vision disturbances (NVD). This segment also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Night Vision Disturbances Market Outlook
The Night Vision Disturbances market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of Nyxol by evaluating its impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
Night Vision Disturbances Drugs Uptake
This section focuses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017 - 2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
Key Report Insights
Market Size and Trends
Impact of upcoming Therapies
Key Report Strengths
10 Years Forecast
The United States Coverage
Key Cross Competition
Market Size by Therapies
Key Report Benefits
This report will help to develop Business Strategies by understanding the trends shaping and driving Night Vision Disturbances market
Organize sales and marketing efforts by identifying the best opportunities for Night Vision Disturbances market
To understand the future market competition in the Night Vision Disturbances market.
Key Topics Covered:
1. Key Insights
2. Disease Background and Overview
2.2. Types of NVD
2.3. Causes and Risk Factors
2.4. Etiology of NVD
3. Epidemiology and Patient Population
3.1. Key Findings
3.2. Assumptions and Rationale
3.3. Total Incident Cases of NVD in the United States
3.4. Incident cases of NVD by Type of Surgeries in the United States
3.5. Incidence of NVD Manifestations in the United States
5. Unmet needs
6. Emerging Drugs
6.1. Nyxol: Ocuphire Pharma
6.2. Safety and Efficacy
6.3. Product Profile
7. Night Vision Disturbances (NVD): The United States Market
7.1. Market Outlook
7.2. Key Findings
7.3. Market Size of NVD in the United States
7.4. Market Size of NVD by Therapies
8. Market Barriers
9. Market Drivers
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/4ev3es.
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005924/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900